Most not too long ago, it has been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds into a big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger and won't acti… Read More